GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » E10

Daehan New Pharm Co (XKRX:054670) E10 : ₩0.00 (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Daehan New Pharm Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩191.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩0.00 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Daehan New Pharm Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Daehan New Pharm Co was 40.50% per year. The lowest was -187.20% per year. And the median was 3.70% per year.

As of today (2025-04-03), Daehan New Pharm Co's current stock price is ₩6690.00. Daehan New Pharm Co's E10 for the quarter that ended in Dec. 2024 was ₩0.00. Daehan New Pharm Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Daehan New Pharm Co was 9130.43. The lowest was 23.48. And the median was 43.56.


Daehan New Pharm Co E10 Historical Data

The historical data trend for Daehan New Pharm Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co E10 Chart

Daehan New Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -141.85 -41.28 182.79 295.01 -

Daehan New Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.01 324.90 - - -

Competitive Comparison of Daehan New Pharm Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Daehan New Pharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daehan New Pharm Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daehan New Pharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Daehan New Pharm Co's Shiller PE Ratio falls into.


;
;

Daehan New Pharm Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daehan New Pharm Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=191/121.1352*121.1352
=191.000

Current CPI (Dec. 2024) = 121.1352.

Daehan New Pharm Co Quarterly Data

per share eps CPI Adj_EPS
201503 90.600 99.721 110.056
201506 98.000 100.051 118.652
201509 93.000 100.111 112.531
201512 14.000 100.220 16.922
201603 95.000 100.561 114.437
201606 113.000 100.791 135.809
201609 56.000 101.461 66.859
201612 -669.000 101.561 -797.936
201703 120.000 102.851 141.333
201706 -1,244.000 102.611 -1,468.573
201709 162.000 103.491 189.620
201712 -505.000 102.991 -593.968
201803 208.000 104.101 242.036
201806 -485.000 104.130 -564.202
201809 316.000 105.651 362.315
201812 135.000 104.351 156.714
201903 226.000 104.491 261.999
201906 245.000 104.881 282.970
201909 223.000 105.200 256.778
201912 390.000 105.121 449.412
202003 258.000 105.354 296.646
202006 273.000 105.112 314.617
202009 -82.000 106.198 -93.534
202012 -1,170.000 105.765 -1,340.024
202103 283.000 107.357 319.320
202106 332.000 107.579 373.837
202109 365.000 108.759 406.534
202112 118.000 109.676 130.328
202203 827.000 111.848 895.669
202206 233.000 114.072 247.426
202209 422.000 114.715 445.617
202212 250.000 115.179 262.928
202303 315.000 116.507 327.512
202306 458.000 117.182 473.450
202309 355.000 118.964 361.480
202312 -234.000 118.837 -238.525
202403 372.000 120.123 375.134
202406 399.000 120.007 402.750
202409 140.000 120.861 140.317
202412 191.000 121.135 191.000

Add all the adjusted EPS together and divide 10 will get our e10.


Daehan New Pharm Co  (XKRX:054670) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Daehan New Pharm Co was 9130.43. The lowest was 23.48. And the median was 43.56.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Daehan New Pharm Co E10 Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co Headlines

No Headlines